Jim Simons Virpax Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.24 - $0.82 $9,744 - $33,292	-40,600 Reduced 57.1%	30,500 $10,000
Q3 2023 Nov 14, 2023	SELL	$0.76 - $1.1 $13,873 - $20,079	-18,254 Reduced 20.43%	71,100 $57,000
Q2 2023 Aug 11, 2023	SELL	$0.64 - $1.09 $3,805 - $6,481	-5,946 Reduced 6.24%	89,354 $97,000
Q1 2023 May 12, 2023	SELL	$0.67 - $1.15 $603 - $1,035	-900 Reduced 0.94%	95,300 $75,000
Q4 2022 Feb 13, 2023	SELL	$0.62 - $12.0 $38,515 - $745,464	-62,122 Reduced 39.24%	96,200 $60,000
Q3 2022 Nov 14, 2022	SELL	$1.15 - $11.9 $51,609 - $534,048	-44,878 Reduced 22.09%	158,322 $188,000
Q2 2022 Aug 12, 2022	BUY	$1.22 - $2.25 $56,852 - $104,850	46,600 Added 29.76%	203,200 $341,000
Q1 2022 May 13, 2022	BUY	$1.86 - $3.61 $291,276 - $565,326	156,600 New	156,600 $348,000

Ticker VRPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,714,600
Market Cap $7.15M
Description
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical no...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.